Literature DB >> 10090745

The effect of membrane composition on the hemostatic balance.

M D Smirnov1, D A Ford, C T Esmon, N L Esmon.   

Abstract

The phospholipid composition requirements for optimal prothrombin activation and factor Va inactivation by activated protein C (APC) anticoagulant were examined. Vesicles composed of phosphatidylethanolamine (PE) and phosphatidylcholine (PC) supported factor Va inactivation relatively well. However, optimal factor Va inactivation still required relatively high concentrations of phosphatidylserine (PS). In addition, at a fixed concentration of phospholipid, PS, and APC, vesicles devoid of PE never attained a rate of factor Va inactivation achievable with vesicles containing PE. Polyunsaturation of any vesicle component also contributed significantly to APC inactivation of factor Va. Thus, PE makes an important contribution to factor Va inactivation that cannot be mimicked by PS. In the absence of polyunsaturation in the other membrane constituents, this contribution was dependent upon the presence of both the PE headgroup per se and unsaturation of the 1,2 fatty acids. Although PE did not affect prothrombin activation rates at optimal PS concentrations, PE reduced the requirement for PS approximately 10-fold. The Km(app) for prothrombin and the Kd(app) for factor Xa-factor Va decreased as a function of increasing PS concentration, reaching optimal values at 10-15% PS in the absence of PE but only 1% PS in the presence of PE. Fatty acid polyunsaturation had minimal effects. A lupus anticoagulant immunoglobulin was more inhibitory to both prothrombinase and factor Va inactivation in the presence of PE. The degree of inhibition of APC was significantly greater and much more dependent on the phospholipid composition than that of prothrombinase. Thus, subtle changes in the phospholipid composition of cells may control procoagulant and anticoagulant reactions differentially under both normal and pathological conditions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10090745     DOI: 10.1021/bi982538b

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

Review 1.  Is testing for antiphosphatidylethanolamine antibodies clinically useful?

Authors:  Marielle Sanmarco
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

Review 2.  Lantibiotics as probes for phosphatidylethanolamine.

Authors:  Ming Zhao
Journal:  Amino Acids       Date:  2009-11-22       Impact factor: 3.520

3.  Microparticles formed during storage of red blood cell units support thrombin generation.

Authors:  Beth A Bouchard; Thomas Orfeo; Hollis N Keith; Elizabeth M Lavoie; Matthew Gissel; Mark Fung; Kenneth G Mann
Journal:  J Trauma Acute Care Surg       Date:  2018-04       Impact factor: 3.313

4.  Modulation of prothrombinase assembly and activity by phosphatidylethanolamine.

Authors:  Rinku Majumder; Xiaoe Liang; Mary Ann Quinn-Allen; William H Kane; Barry R Lentz
Journal:  J Biol Chem       Date:  2011-08-22       Impact factor: 5.157

5.  Prothrombin activation on the activated platelet surface optimizes expression of procoagulant activity.

Authors:  Jeremy P Wood; Jay R Silveira; Nicole M Maille; Laura M Haynes; Paula B Tracy
Journal:  Blood       Date:  2010-12-03       Impact factor: 22.113

6.  Inhibition of APC anticoagulant activity on oxidized phospholipid by anti-{beta}2-glycoprotein I monoclonal antibodies.

Authors:  Omid Safa; Charles T Esmon; Naomi L Esmon
Journal:  Blood       Date:  2005-05-12       Impact factor: 22.113

7.  Activated protein C: a potential cardioprotective factor against ischemic injury during ischemia/reperfusion.

Authors:  Jingying Wang; Ji Li
Journal:  Am J Transl Res       Date:  2009-07-15       Impact factor: 4.060

8.  Phosphatidylethanolamine is externalized at the surface of microparticles.

Authors:  Michael C Larson; Jeffrey E Woodliff; Cheryl A Hillery; Tyce J Kearl; Ming Zhao
Journal:  Biochim Biophys Acta       Date:  2012-08-30

9.  Prothrombotic skeletal muscle myosin directly enhances prothrombin activation by binding factors Xa and Va.

Authors:  Hiroshi Deguchi; Ranjeet K Sinha; Patrizia Marchese; Zaverio M Ruggeri; Jevgenia Zilberman-Rudenko; Owen J T McCarty; Mitchell J Cohen; John H Griffin
Journal:  Blood       Date:  2016-07-15       Impact factor: 22.113

10.  Crystal structure of the bovine lactadherin C2 domain, a membrane binding motif, shows similarity to the C2 domains of factor V and factor VIII.

Authors:  Lin Lin; Qing Huai; Mingdong Huang; Bruce Furie; Barbara C Furie
Journal:  J Mol Biol       Date:  2007-05-25       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.